Charles River Laboratories International IncNYSE:CRL
- LAST PRICE206.2000
- TODAY'S CHANGE (%)-0.1900 (-0.0921%)
- Bid / Lots206.0400/ 3
- Ask / Lots206.3600/ 2
- Open / Previous Close205.8800 / 206.3900
- Day Range
- 52 Week Range
- Volume151,204
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | CRL |
|---|---|---|
| 09:38 ET | 449 | 204.6169 |
| 09:39 ET | 300 | 204.06 |
| 09:41 ET | 700 | 204.6 |
| 09:43 ET | 951 | 204.62 |
| 09:45 ET | 500 | 204.02 |
| 09:48 ET | 1300 | 204.31 |
| 09:50 ET | 178 | 204.345 |
| 09:52 ET | 300 | 204.12 |
| 09:57 ET | 300 | 204.39 |
| 09:59 ET | 600 | 204.19 |
| 10:01 ET | 300 | 204.5 |
| 10:10 ET | 405 | 204.83 |
| 10:12 ET | 200 | 204.83 |
| 10:14 ET | 100 | 204.95 |
| 10:19 ET | 200 | 205.17 |
| 10:24 ET | 2100 | 205.43 |
| 10:28 ET | 1200 | 205.175 |
| 10:30 ET | 200 | 204.88 |
| 10:32 ET | 1100 | 204.57 |
| 10:33 ET | 200 | 204.704 |
| 10:35 ET | 400 | 204.69 |
| 10:37 ET | 997 | 204.665 |
| 10:39 ET | 200 | 204.66 |
| 10:42 ET | 565 | 204.54 |
| 10:44 ET | 100 | 204.35 |
| 10:48 ET | 355 | 204.43 |
| 10:50 ET | 1136 | 204.47 |
| 10:53 ET | 600 | 204.475 |
| 10:55 ET | 300 | 204.475 |
| 10:57 ET | 2407 | 204.745 |
| 11:00 ET | 500 | 204.825 |
| 11:02 ET | 100 | 204.86 |
| 11:06 ET | 838 | 204.76 |
| 11:08 ET | 3811 | 204.285 |
| 11:09 ET | 2100 | 203.64 |
| 11:11 ET | 100 | 203.63 |
| 11:15 ET | 870 | 203.71 |
| 11:18 ET | 100 | 203.81 |
| 11:20 ET | 600 | 204.15 |
| 11:22 ET | 402 | 204.34 |
| 11:24 ET | 400 | 204.46 |
| 11:26 ET | 100 | 204.465 |
| 11:29 ET | 100 | 204.67 |
| 11:31 ET | 200 | 204.85 |
| 11:33 ET | 200 | 204.955 |
| 11:38 ET | 100 | 205.115 |
| 11:40 ET | 100 | 205.135 |
| 11:42 ET | 275 | 204.96 |
| 11:45 ET | 208 | 205.345 |
| 11:49 ET | 1400 | 204.75 |
| 11:51 ET | 400 | 204.93 |
| 11:54 ET | 100 | 204.84 |
| 11:56 ET | 1525 | 204.83 |
| 11:58 ET | 1697 | 204.785 |
| 12:00 ET | 400 | 204.725 |
| 12:03 ET | 1137 | 204.31 |
| 12:05 ET | 100 | 204.335 |
| 12:07 ET | 1821 | 204.56 |
| 12:09 ET | 100 | 204.76 |
| 12:12 ET | 241 | 204.83 |
| 12:14 ET | 100 | 204.55 |
| 12:16 ET | 100 | 204.695 |
| 12:18 ET | 100 | 204.69 |
| 12:20 ET | 600 | 204.97 |
| 12:21 ET | 300 | 205.01 |
| 12:23 ET | 100 | 205.09 |
| 12:25 ET | 200 | 205.02 |
| 12:27 ET | 500 | 205.18 |
| 12:32 ET | 415 | 204.8201 |
| 12:34 ET | 600 | 204.73 |
| 12:36 ET | 1200 | 205.105 |
| 12:38 ET | 100 | 205.125 |
| 12:39 ET | 545 | 205.29 |
| 12:41 ET | 200 | 205.275 |
| 12:43 ET | 1100 | 205.3 |
| 12:45 ET | 100 | 205.23 |
| 12:48 ET | 500 | 205.58 |
| 12:52 ET | 300 | 205.665 |
| 12:54 ET | 100 | 205.67 |
| 12:56 ET | 100 | 205.56 |
| 12:57 ET | 1043 | 205.82 |
| 12:59 ET | 505 | 205.65 |
| 01:01 ET | 300 | 205.4 |
| 01:06 ET | 100 | 205.475 |
| 01:14 ET | 100 | 205.33 |
| 01:17 ET | 400 | 205.27 |
| 01:19 ET | 513 | 205.19 |
| 01:21 ET | 100 | 205.085 |
| 01:24 ET | 100 | 205.105 |
| 01:26 ET | 200 | 205.115 |
| 01:30 ET | 200 | 205.145 |
| 01:32 ET | 100 | 205.23 |
| 01:33 ET | 100 | 205.46 |
| 01:35 ET | 500 | 205.35 |
| 01:37 ET | 100 | 205.43 |
| 01:39 ET | 200 | 205.31 |
| 01:46 ET | 843 | 205.23 |
| 01:51 ET | 200 | 205.14 |
| 01:55 ET | 3869 | 205.49 |
| 01:57 ET | 100 | 205.455 |
| 02:00 ET | 100 | 205.54 |
| 02:04 ET | 114 | 205.48 |
| 02:06 ET | 200 | 205.68 |
| 02:08 ET | 507 | 205.85 |
| 02:09 ET | 994 | 205.6213 |
| 02:11 ET | 998 | 205.855 |
| 02:13 ET | 1260 | 206.09 |
| 02:15 ET | 300 | 206.43 |
| 02:18 ET | 600 | 206.645 |
| 02:20 ET | 100 | 206.37 |
| 02:22 ET | 333 | 206.305 |
| 02:24 ET | 400 | 205.855 |
| 02:27 ET | 213 | 205.835 |
| 02:29 ET | 119 | 205.825 |
| 02:33 ET | 200 | 205.81 |
| 02:36 ET | 100 | 205.93 |
| 02:38 ET | 100 | 205.9 |
| 02:40 ET | 100 | 205.855 |
| 02:42 ET | 200 | 205.855 |
| 02:45 ET | 708 | 205.945 |
| 02:49 ET | 600 | 205.995 |
| 02:54 ET | 3448 | 206.22 |
| 02:56 ET | 300 | 206.32 |
| 02:58 ET | 900 | 206.265 |
| 03:02 ET | 300 | 206.2 |
| 03:03 ET | 200 | 206.2 |
Yesterday
Agilon Health, Inc, B. Riley Financial, Charles River Laboratories, and Vertex Energy Investigation Alert: Johnson Fistel, LLP Encourages Long-Term Investors to Reach Out for More Information, from 11:15AM ET on Tuesday Jun 25, 2024 by Dow Jones
11:15AM ET on Tuesday Jun 25, 2024 by Dow JonesCharles River Laboratories Announces Strategic Lentiviral Vector Manufacturing Collaboration with Gates Institute at University of Colorado Anschutz Medical Campus, from 8:00AM ET on Tuesday Jun 25, 2024 by Dow Jones
8:00AM ET on Tuesday Jun 25, 2024 by Dow Jones
Jun 20, 2024
Jun 17, 2024
CRL INVESTIGATION ALERT: Johnson Fistel LLP Investigates Charles River Laboratories' Directors and Officers for Breach of Fiduciary Duties, from 12:05PM ET on Monday Jun 17, 2024 by Dow Jones
12:05PM ET on Monday Jun 17, 2024 by Dow JonesCharles River and Captain T Cell Announce Plasmid DNA and Viral Vector Manufacturing Alliance for Gene-Modified Cell Therapy, from 8:00AM ET on Monday Jun 17, 2024 by Dow Jones
8:00AM ET on Monday Jun 17, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Charles River Laboratories International Inc | 10.6B | 24.2x | +15.57% |
Incyte Corp | 14.2B | 18.7x | +39.11% |
Biontech SE | 20.1B | 162.6x | --- |
Exact Sciences Corp | 7.6B | -33.4x | --- |
Fortrea Holdings Inc | 2.0B | -20.2x | --- |
United Therapeutics Corp | 14.2B | 15.1x | +8.22% |
Company Information
Charles River Laboratories International, Inc. provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and academic institutions around the globe accelerate their research and drug development efforts. The Company's Research Models and Services segment is comprised of three businesses that provide foundational tools that enables its clients to discover new molecules: Research Models, Research Model Services, and Cell Solutions. Its Discovery and Safety Assessment segment provides regulated and non-regulated DSA services to support the research, development, and regulatory-required safety testing of potential new drugs, including therapeutic discovery and optimization plus in vitro and in vivo studies, laboratory support services, and strategic non-clinical consulting and program management to support product development. Its Manufacturing Solutions segment includes Microbial Solutions and Biologics Solutions.
Contact Information
- Headquarters
- 251 Ballardvale StWILMINGTON, MA, United States 01887
- Phone
- 781-222-6000
- Fax
- 978-988-5665
Executives
- Chairman of the Board, President, Chief Executive Officer
- James Foster
- Chief Financial Officer, Corporate Executive Vice President
- Flavia Pease
- Chief Operating Officer, Corporate Executive Vice President
- Birgit Girshick
- Corporate Executive Vice President and Chief People Officer
- Victoria Creamer
- Executive Vice President, Strategic Advisor
- William Barbo
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $10.6B |
|---|---|
Revenue (TTM) | $4.1B |
Shares Outstanding | 51.5M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.38 |
EPS | $8.52 |
Book Value | $70.06 |
P/E Ratio | 24.2x |
Price/Sales (TTM) | 2.6 |
Price/Cash Flow (TTM) | 13.7x |
Operating Margin | 13.99% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
